Spi-B-Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28754672.
- Also identified by DOI 10.1158/0008-5472.CAN-17-0020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dissociation from epithelial sheets and invasion through the surrounding stroma are critical early events during epithelial cancer metastasis. Here we find that a lymphocyte lineage-restricted transcription factor, Spi-B, is frequently expressed in human lung cancer tissues. The Spi-B-expressing cancer cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior. Increased Spi-B expression was associated with tumor grade, lymphatic metastasis, and short overall survival. Mechanistically, Spi-B disrupted intercellular junctions and enhanced invasiveness by reconfiguring the chromatin structure of the tight junction gene claudin-2 (<i>CLDN2</i>) and repressing its transcription. These data suggest that Spi-B participates in mesenchymal invasion, linking epithelial cancer metastasis with a lymphatic transcriptional program. <i>Cancer Res; 77(18); 4809-22. ©2017 AACR</i>.
Medical subject headings
- Carcinoma, Lewis Lung
- Claudin-2
- DNA-Binding Proteins
- Gene Expression Regulation, Neoplastic
- Lung Neoplasms
- Transcription Factors